These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28836043)

  • 21. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
    Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
    BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.
    Zhuang XP; Jin WW; Teng XD; Yuan ZZ; Lin QQ; Xu ST
    Eur J Gynaecol Oncol; 2015; 36(3):255-9. PubMed ID: 26189249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
    Bai JDK; Babu S; Roa-Peña L; Hou W; Akalin A; Escobar-Hoyos LF; Shroyer KR
    Hum Pathol; 2019 Dec; 94():40-50. PubMed ID: 31655172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53.
    Brunner AH; Riss P; Heinze G; Meltzow E; Brustmann H
    Int J Gynecol Pathol; 2011 Nov; 30(6):569-75. PubMed ID: 21979593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotensin expression and outcome of malignant pleural mesothelioma.
    Alifano M; Loi M; Camilleri-Broet S; Dupouy S; Régnard JF; Forgez P
    Biochimie; 2010 Feb; 92(2):164-70. PubMed ID: 19932148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.
    Kamimae S; Yamamoto E; Kai M; Niinuma T; Yamano HO; Nojima M; Yoshikawa K; Kimura T; Takagi R; Harada E; Harada T; Maruyama R; Sasaki Y; Tokino T; Shinomura Y; Sugai T; Imai K; Suzuki H
    Oncotarget; 2015 Oct; 6(30):29975-90. PubMed ID: 26334593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
    Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.
    Memarzadeh S; Kozak KR; Chang L; Natarajan S; Shintaku P; Reddy ST; Farias-Eisner R
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10647-52. PubMed ID: 12130664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas.
    Brüning A; Jückstock J; Blankenstein T; Makovitzky J; Kunze S; Mylonas I
    Histol Histopathol; 2010 Nov; 25(11):1447-56. PubMed ID: 20865667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas.
    Allard JE; Risinger JI; Morrison C; Young G; Rose GS; Fowler J; Berchuck A; Maxwell GL
    Gynecol Oncol; 2007 Oct; 107(1):52-7. PubMed ID: 17582475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer.
    Seeger A; Kölbl H; Petry IB; Gebhard S; Battista MJ; Böhm D; Steiner E
    Gynecol Oncol; 2012 Apr; 125(1):200-7. PubMed ID: 22210468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
    Takahashi K; Ehata S; Miyauchi K; Morishita Y; Miyazawa K; Miyazono K
    Mol Oncol; 2021 Jan; 15(1):151-166. PubMed ID: 33034134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
    Soovares P; Pasanen A; Bützow R; Lassus H
    Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
    Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.
    Kim JT; Li J; Song J; Lee EY; Weiss HL; Townsend CM; Evers BM
    Oncotarget; 2015 Sep; 6(29):26960-70. PubMed ID: 26298774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
    Kim JT; Weiss HL; Evers BM
    Int J Oncol; 2017 Jun; 50(6):2200-2206. PubMed ID: 28498396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
    Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
    Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.